Supplementary Methods

Patients
The study involved MPN patients who were followed at the Division of Hematology, Coriell Cell Repositories, Coriell Institute (NJ, USA). All cells were maintained according to the distributor's recommendation.
Cell lines
Stable cells co-expressing thrombopoietin receptor MPL and mutated CALR
Considering that mutated CALR needs the presence of thrombopoietin receptor MPL to exert its effect on MPN phenotype, 6, 7 we established stable Ba/F3 cells co-expressing MPL and either type 1 or type 2 CALR mutant to assess the effects of CALR mutation on cellular phenotypes. These cells were generated from mutated CALR constructs (5-bps insertion, INS; 52-bps deletion, DEL, both plasmids were kindly provided by Professor Tony R. Green, University of Cambridge, UK) and
MPL (Human TPO expression plasmid, C-Flag, Sino Biological Inc.) co-transfection.
Stable colonies were selected and maintained in medium containing G418 (500 g/ml) and hygromycin (400 g/ml).
Real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis
RNA isolation, DNA contamination removal, and first-strand cDNA synthesis were carried out as previously described. 8 The expression level of HMGA2 was measured by qRT-PCR using iTaq™ Universal Probes Supermix (Bio-Rad, Hercules, CA, USA). Relative gene expression was calculated using the 2 −ΔΔCT method. 4 To analyze the expression of let-7a microRNA and internal control snoRNA202, 10 ng of total RNA were reverse transcribed into cDNA using TagMan MicroRNA assays (Applied Biosystem, Carlsbad, CA, USA) under the following conditions:
16°C for 30 min, 42°C for 30 min, and 85°C for 5 min. Each cDNA generated was amplified by quantitative PCR using sequence-specific primers from the TaqMan microRNA assay on a Qiagen Rotor Gene Q system (Qiagen, Hilden, Germany). The reactions were incubated at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. We used snoRNA202 as the internal control for miRNA detection.
The relative expression level of let-7a was normalized to that of snoRNA202 microRNA.
Fluorescence in situ hybridization (FISH)
Paraffin cell blocks obtained from PB granulocytes of MPN patients were cut at 5 m.
Slides were deparaffinized in xylene, dehydrated in 100% ethanol and then allowed to dry. A human HMGA2 FITC probe, spanning a 430-kb region located on chromosome 12q15 that covers the whole HMGA2 gene, was purchased from Abnova.
Hybridization was performed following standard protocol. Due to either insufficient sample volume or inadequate quality of sample processing, we did FISH analysis in only 14 HMGA2 (+), 14 HMGA2 (-) and 10 normal control samples. We counted at least 50 cells for each sample.
Western blot analysis
Following treatment in respective experiments, cells were harvested, washed with PBS twice, and then resuspended in RIPA buffer (Thermo Scientific, Carlsbad, CA, USA) with the addition of 1X protease inhibitor (Thermo Scientific), 1X phosphatase inhibitor (Thermo Scientific) and 0.1% SDS (Invitrogen, Carlsbad, CA, USA).
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Lysates were incubated on ice for 15-30 min, followed by sonication and centrifugation at 14,000 ×g for 15 min. The supernatants were collected and quantified. Equal amounts of lysate (on a protein basis) were separated by SDS-PAGE, blotted onto polyvinylidene difluoride membranes, conjugated with various specific primary antibodies, and then probed with appropriate secondary antibodies. The immunoreactive bands were detected using the enhanced chemiluminescence method and visualized on Kodak Bio MAX MR film.
Poly (ADP-ribose) polymerase (PARP) is a family of proteins involved in a number of cellular processes, especially programmed cell death, 9 and cleavage of PARP serves as a marker of cells undergoing apoptosis. Moreover, Bcl-2-associated death promoter (BAD) protein is a pro-apoptotic member of the Bcl-2 gene family which is involved in initiating apoptosis by displacing Bax from binding to Bcl-2. 10 Phosphorylation of BAD (p-BAD) at Ser112 and Ser136 inhibits apoptotic activity. 11 We used PARP antibody (1:3000, Cell Signaling Technology, Danvers, MA, USA) as well as BAD and p-BAD antibodies (1:3000, Cell Signaling Technology) to assess the degree of apoptosis. Primary antibodies against other proteins and their working concentrations were as follows: JAK2 (1:10,000; Abcam, Cambridge, UK), p-JAK2
(1:2,000; Cell Signaling Technology), p-STAT3 (1:1,000; Cell Signaling Technology), p-STAT5 (1:1,000; Cell Signaling Technology), HMGA2 (1:10,000, Santa Cruz Biotechnology, Santa Cruz, CA, USA), LIN28A (1:1,000; Cell Signaling Technology) and -actin (1:10,000; Sigma-Aldrich, St. Louis, MO, USA). Finally, anti-mouse and anti-rabbit secondary antibodies (both from Jackson ImmunoResearch) were used in a 1/10000 dilution.
